News

The Division of Intramural Research provides fundamental knowledge about the nature and behavior of living systems through basic, clinical, and population-based research.

The Division of Intramural Research provides fundamental knowledge about the nature and behavior of living systems through basic, clinical, and population-based research.

NIH’s BRAIN Initiative is marking a milestone—10 years of advancing neuroscience and neurotechnology research by funding innovative projects. Dr. Bianchi shares her perspective on the impact BRAIN has made on NICHD’s mission.

NICHD scientists and colleagues identified genetic variants that disable the protein complex BORC as the cause of a severe neurodegenerative disorder that begins early in life. Subsequent work helped unravel the role of BORC in neurons and explain how defects in BORC function may contribute to neurodegeneration.

Gisela Storz, Ph.D., an NIH Distinguished Investigator at NICHD has been elected as a fellow of the American Association for the Advancement of Science (AAAS). Dr. Storz was honored for her distinguished contributions to the field of microbiology.

Anomalies of the vascular system include lymphatic malformations that can cause lymphedema, or swelling in parts of the body. These anomalies arise from gene mutations that can be hereditary or occur spontaneously after conception. Research led by the Sheppard Lab at NICHD is seeking to understand the genetic causes of vascular anomalies, examine how they change over a lifetime, and identify drugs to treat them.

Infertility affects millions of lives. NICHD supports research to better understand its causes and contributing factors and to improve treatments for both male and female inferility.

The Division of Intramural Research provides fundamental knowledge about the nature and behavior of living systems through basic, clinical, and population-based research.

NICHD’s Tracey Rouault, M.D., has had many notable achievements during her nearly four-decade career in the intramural program at NIH. Learn about her upbringing, career path, and accomplishments.

An atlas of the placenta developed by NIH researchers offers insight on the communication that occurs between maternal and fetal cells during labor and delivery.

In 2023, NICHD continued its commitment to research to understand human development, improve reproductive health, promote women’s health, enhance the lives of children and adolescents, and optimize abilities for all. Highlights include steps toward reducing the global burden of maternal sepsis and establishing a standard treatment for opioid-exposed newborns.

Zebrafish are models for studying early development. Scientists at NICHD published an atlas of early zebrafish development that can serve as resource for other researchers who study development or human conditions and diseases.

As we ring in 2024, we’d like to take a brief look back on our accomplishments during 2023. These activities illustrate the institute’s continued commitment to research and training in its mission areas.

The Division of Intramural Research provides fundamental knowledge about the nature and behavior of living systems through basic, clinical, and population-based research.

Researchers at NIH have developed a model of how mitochondria—the energy producers in cells—obtain the essential mineral magnesium through the Mitochondrial RNA Splicing 2 (MRS2) channel.

The properties of neuronal junctions that help form long-term memories and aid in learning are similar between mice and people, according to a new NIH study.

The Division of Intramural Research provides fundamental knowledge about the nature and behavior of living systems through basic, clinical, and population-based research.

Catherine Gordon, M.D., M.S., has been appointed clinical director at NICHD. In her new role, she will lead the institute’s intramural clinical research program to improve understanding of the biological, medical, reproductive, and behavioral aspects of typical and atypical human development.

Children with creatine transporter deficiency, a hereditary developmental disorder, have higher levels of three proteins that are also found in people with Alzheimer’s disease, according to a small study by researchers at NIH and other institutions. The higher the level of proteins, the lower the children scored on a test of coping behaviors and skills. These findings may help inform diagnostic approaches for the transporter deficiency disorder.

A microscopy image created by NIH researchers is part of the “Life Magnified” stamp panel issued by the United States Postal Service.